{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:54:39Z","timestamp":1790884479693,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The metabolic dysfunction\u2013associated steatotic liver disease (MASLD) framework emphasizes the central role of metabolic disturbances in fatty liver disease. Fat-related metabolic indices integrate information on insulin resistance and adiposity; however, their associations with MASLD and hepatic fibrosis at the population level have not been fully elucidated. Thus, this study aimed to examine the associations of 6 fat-related metabolic indices with MASLD and liver fibrosis in a nationally representative U.S. population. We analyzed data from the National Health and Nutrition Examination Survey 2017\u20132020. Six fat-related metabolic indices: metabolic score for insulin resistance, metabolic score for visceral fat, cardiometabolic index, triglyceride-glucose index, waist triglyceride index, and lipid accumulation product, were calculated and categorized into quartiles. Hepatic steatosis and fibrosis were assessed using vibration-controlled transient elastography based on controlled attenuation parameter and liver stiffness measurement. Multivariable regression analyses were performed with progressive adjustment for potential confounders. All 6 indices exhibited significant dose\u2013response associations with controlled attenuation parameter and MASLD prevalence. Higher quartiles were consistently associated with increased odds of MASLD after full adjustment. Positive associations with liver stiffness measurement and liver fibrosis were also observed, although the magnitude of associations was attenuated after comprehensive covariate adjustment. Among the indices, metabolic indices: metabolic score for insulin resistance, metabolic score for visceral fat, cardiometabolic index and lipid accumulation product demonstrated the strongest discriminative ability for liver fibrosis. Fat-related metabolic indices reflecting insulin resistance and adiposity are closely associated with MASLD and liver fibrosis in the general population, highlighting their relevance to metabolic liver disease phenotypes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049644","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:01:27Z","timestamp":1783720887000},"page":"e49644","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association of fat-related metabolic indices with MASLD and liver fibrosis: a cross-sectional analysis of NHANES 2017\u20132020"],"prefix":"10.1097","volume":"105","author":[{"given":"Neng","family":"Shen","sequence":"first","affiliation":[{"name":"The Third People\u2019s Hospital of Yinzhou District, Ningbo, Zhejiang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Wei","sequence":"additional","affiliation":[{"name":"The Third People\u2019s Hospital of Yinzhou District, Ningbo, Zhejiang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Fourth People\u2019s Hospital of Yuyao, Ningbo, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0222-4089","authenticated-orcid":false,"given":"Jiacheng","family":"Cai","sequence":"additional","affiliation":[{"name":"The Third People\u2019s Hospital of Yinzhou District, Ningbo, Zhejiang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261001","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments.","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R2-20261001","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: how is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"R3-20261001","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00535-023-02021-7","article-title":"MAFLD: an optimal framework for understanding liver cancer phenotypes.","volume":"58","author":"Crane","year":"2023","journal-title":"J Gastroenterol"},{"key":"R4-20261001","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"R5-20261001","doi-asserted-by":"crossref","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature.","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann Hepatol"},{"key":"R6-20261001","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications.","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"R7-20261001","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-17-0883","article-title":"METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes.","volume":"178","author":"Bello-Chavolla","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"R8-20261001","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.clnu.2019.07.012","article-title":"Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health.","volume":"39","author":"Bello-Chavolla","year":"2020","journal-title":"Clin Nutr"},{"key":"R9-20261001","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s13105-016-0505-5","article-title":"Effects of improved fat meat products consumption on emergent cardiovascular disease markers of male volunteers at cardiovascular risk.","volume":"72","author":"Celada","year":"2016","journal-title":"J Physiol Biochem"},{"key":"R10-20261001","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/pedi.12303","article-title":"Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp.","volume":"17","author":"Mohd Nor","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"R11-20261001","doi-asserted-by":"crossref","first-page":"1570740","DOI":"10.3389\/fnut.2025.1570740","article-title":"Abdominal obesity and osteoarthritis risk: evaluating the association of lipid accumulation product, body roundness index, and waist triglyceride index with osteoarthritis in U.S. adults.","volume":"12","author":"Li","year":"2025","journal-title":"Front Nutr"},{"key":"R12-20261001","doi-asserted-by":"crossref","first-page":"889785","DOI":"10.3389\/fendo.2022.889785","article-title":"Association between four anthropometric indexes and metabolic syndrome in US adults.","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R13-20261001","doi-asserted-by":"crossref","first-page":"101419","DOI":"10.1016\/j.jhepr.2025.101419","article-title":"Identification of pediatric MASLD using insulin resistance indices.","volume":"7","author":"Song","year":"2025","journal-title":"JHEP Rep"},{"key":"R14-20261001","doi-asserted-by":"crossref","first-page":"101547","DOI":"10.1016\/j.eclinm.2022.101547","article-title":"Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"51","author":"Cao","year":"2022","journal-title":"EClinicalMedicine"},{"key":"R15-20261001","doi-asserted-by":"crossref","first-page":"1272321","DOI":"10.3389\/fnut.2023.1272321","article-title":"Association between dietary intakes of B vitamins and nonalcoholic fatty liver disease in postmenopausal women: a cross-sectional study.","volume":"10","author":"Li","year":"2023","journal-title":"Front Nutr"},{"key":"R16-20261001","doi-asserted-by":"crossref","first-page":"1022928","DOI":"10.3389\/fpubh.2022.1022928","article-title":"Associations of serum folate and vitamin C levels with metabolic dysfunction-associated fatty liver disease in US adults: a nationwide cross-sectional study.","volume":"10","author":"Jiang","year":"2022","journal-title":"Front Public Health"},{"key":"R17-20261001","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jdiacomp.2016.05.014","article-title":"Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome.","volume":"30","author":"Mikolasevic","year":"2016","journal-title":"J Diabetes Complications"},{"key":"R18-20261001","doi-asserted-by":"crossref","first-page":"113647","DOI":"10.1016\/j.envres.2022.113647","article-title":"Association of blood manganese, selenium with steatosis, fibrosis in the National Health and Nutrition Examination Survey, 2017-18.","volume":"213","author":"Spaur","year":"2022","journal-title":"Environ Res"},{"key":"R19-20261001","doi-asserted-by":"crossref","first-page":"186","DOI":"10.15585\/mmwr.mm6706a3","article-title":"Prevalence of obesity among youths by household income and education level of head of household - United States 2011-2014.","volume":"67","author":"Ogden","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R20-20261001","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1001\/jama.2018.14854","article-title":"The Physical Activity Guidelines for Americans.","volume":"320","author":"Piercy","year":"2018","journal-title":"JAMA"},{"key":"R21-20261001","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jand.2018.05.007","article-title":"Dietary guidelines 2020-2025: update on academy efforts.","volume":"119","author":"Tuma","year":"2019","journal-title":"J Acad Nutr Diet"},{"key":"R22-20261001","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.aohep.2020.03.006","article-title":"Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: a nationwide survey (NHANES 2011-2016).","volume":"19","author":"Reja","year":"2020","journal-title":"Ann Hepatol"},{"issue":"Suppl 1","key":"R23-20261001","first-page":"S62","article-title":"Diagnosis and classification of diabetes mellitus.","volume":"34","year":"2011","journal-title":"Diabetes Care"},{"key":"R24-20261001","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R25-20261001","doi-asserted-by":"crossref","first-page":"1366843","DOI":"10.3389\/fnut.2024.1366843","article-title":"The association between diverse serum folate with MAFLD and liver fibrosis based on NHANES 2017-2020.","volume":"11","author":"Cai","year":"2024","journal-title":"Front Nutr"},{"key":"R26-20261001","first-page":"497","article-title":"Association of systemic inflammatory indices with metabolic dysfunction\u2013associated steatotic liver disease and liver fibrosis.","volume":"37","author":"Wei","year":"2026","journal-title":"Turk J Gastroenterol"},{"key":"R27-20261001","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-319-48382-5_12","article-title":"Insulin resistance, obesity and lipotoxicity.","volume":"960","author":"Yazici","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"R28-20261001","doi-asserted-by":"crossref","first-page":"964","DOI":"10.4093\/dmj.2025.0644","article-title":"Hepatic insulin resistance and steatosis in metabolic dysfunction-associated steatotic liver disease: new insights into mechanisms and clinical implications.","volume":"49","author":"Truong","year":"2025","journal-title":"Diabetes Metab J"},{"key":"R29-20261001","doi-asserted-by":"crossref","first-page":"20470","DOI":"10.1038\/s41598-023-47269-4","article-title":"Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population.","volume":"13","author":"Zeng","year":"2023","journal-title":"Sci Rep"},{"key":"R30-20261001","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12902-025-01988-z","article-title":"Non-linear association between metabolic score for insulin resistance and nonalcoholic fatty liver disease: analysis of US National Health and Nutrition Examination Survey data, 2017-2020.","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"R31-20261001","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1194\/jlr.R066357","article-title":"Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis.","volume":"57","author":"Hirsova","year":"2016","journal-title":"J Lipid Res"},{"key":"R32-20261001","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcmgh.2022.01.007","article-title":"Liver steatosis is a driving factor of inflammation.","volume":"13","author":"Mooli","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R33-20261001","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.7150\/ijbs.47143","article-title":"Kupffer cells in non-alcoholic fatty liver disease: friend or foe?","volume":"16","author":"Chen","year":"2020","journal-title":"Int J Biol Sci"},{"key":"R34-20261001","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1083\/jcb.201903090","article-title":"The cell biology of the hepatocyte: a membrane trafficking machine.","volume":"218","author":"Schulze","year":"2019","journal-title":"J Cell Biol"},{"key":"R35-20261001","first-page":"e75677","article-title":"A comprehensive review of pathophysiological link between non-alcoholic fatty liver disease, insulin resistance, and metabolic syndrome.","volume":"16","author":"Januario","year":"2024","journal-title":"Cureus"},{"key":"R36-20261001","doi-asserted-by":"crossref","first-page":"1620585","DOI":"10.3389\/fimmu.2025.1620585","article-title":"Inflammation: a key mechanism connecting metabolic-associated steatotic liver disease and systemic arterial hypertension.","volume":"16","author":"Solleiro-Villavicencio","year":"2025","journal-title":"Front Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:01:46Z","timestamp":1790881306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":36,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049644","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"2025-12-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}